Agenda

Please see the agenda below to see all topics that will be covered.

Tuesday
Start Time	End Time	Session	Topic	Facilitator	Faculty Presenting	Faculty Hospital
7:30 AM	8:00 AM		Registration / Breakfast
8:00 AM	8:10 AM	Session 9: GI Leaks and Enterocutaneous Fistulae: Multidisciplinary Strategies for Closure and Control	Endoscopic closure of GI leaks and fistulae: over-the-scope clips, endoscopic suturing, and covered stents — patient selection and technique	Michael Terjimanian, MD & Ryan Juza, MD	Ryan Juza, MD	University of Wisconsin
8:10 AM	8:20 AM		IR-guided drainage and fistula management: percutaneous abscess control, fistulography, and tract embolization		Michael Terjimanian, MD	University of Michigan
8:20 AM	8:30 AM		Surgical management of gastrointestinal leaks: timing, source control, nutritional optimization, and definitive repair		Charudutt Paranjape, MD	Mass General Brigham
8:30 AM	8:45 AM		Panel discussion: the post-operative patient with an anastomotic leak, undrained collection, and high-output fistula		Ryan Juza, MD	University of Wisconsin
					Michael Terjimanian, MD	University of Michigan
					Charudutt Paranjape, MD	Mass General Brigham
8:45 AM	8:57 AM	Session 10: Pancreatic Cystic Neoplasms and Low-Grade Malignancies: Diagnosis, Surveillance, and Intervention	EUS-guided diagnosis and risk stratification of pancreatic cystic neoplasms: through-the-needle biopsy, cyst fluid analysis, and emerging molecular markers	Bill Sherk, MD & Kevin El-Hayek, MD, MBA, FACS	Linda Lee, MD	Brigham and Women’s Hospital
8:57 AM	9:09 AM		Endoscopic ablation of pancreatic cysts: EUS-guided ethanol and radiofrequency ablation — evidence and patient selection		Kumar Krishnan, MD	Massachusetts General Hospital
9:09 AM	9:21 AM		Surgical resection of pancreatic cystic neoplasms and low-grade malignancies: minimally invasive pancreatectomy, parenchymal-sparing approaches, and oncologic thresholds		Kevin El-Hayek MD, MBA, FACS	The MetroHealth System
9:21 AM	9:33 AM		IR management of post-pancreatectomy complications: Vascular		Bill Sherk, MD	University of Michigan
9:33 AM	9:45 AM		IR management of post-pancreatectomy complications: Non-Vascular		Keith Quencer, MD	OHSU
9:45 AM	10:00 AM		Panel discussion: the patient with a symptomatic 4 cm branch-duct IPMN and worrisome features		Ashley Faulx, MD	University Hospitals Cleveland Medical Center
					Kumar Krishnan, MD	Massachusetts General Hospital
					Kevin El-Hayek MD, MBA, FACS	The MetroHealth System
					Bill Sherk, MD	University of Michigan
10:00 AM	10:20 AM		Break and Vendor Visiting in Exhibit Lounge
10:20 AM	11:00 AM	Session 11: Keynote Lecture	Advances in Transplant Oncology: Role of Multidisciplinary Patient Centered Care		Shimul Shah, MD	Mass General Brigham
11:00 AM	11:10 AM	Session 12: Hepatocellular Carcinoma (HCC)	Early Hepatocellular Carcinoma in 2026: Expanding Curative Hepatic Resection with Parenchymal-Sparing Strategies, Minimally Invasive Approaches, and Long-Term Oncologic Outcomes	Eric Hoffer, MD & Martin Dib, MD	Martin Dib, MD	Beth Israel Deaconess Medical Center
11:10 AM	11:20 AM		Next-Generation Ablation: Thermal ablation, Histotripsy, Fusion Imaging, and Combination Locoregional Therapy for Early HCC		Paul Shyn, MD	Harvard Medical School, Brigham and Women’s Hospital
11:20 AM	11:30 AM		Liver Transplantation for HCC in the Era of Expanded Criteria: Downstaging, Biology-Based Selection, and Bridging Innovation		Teresa Rice, MD	Mass General Brigham
11:30 AM	11:40 AM		Beyond TACE: Y-90 Radiation Segmentectomy, Personalized Dosimetry, and Systemic Integration in Advanced HCC		Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
11:40 AM	11:50 AM		The Hepatologist’s Role in Modern HCC Management: Risk Stratification, Liver Function Optimization, and Guiding Curative-Intent Multidisciplinary Therapy		Irun Bhan, MD	Massachusetts General Hospital
11:50 AM	12:00 PM		Noon Immunotherapy Revolution in HCC: IO + VEGF Combinations, Peri-Transplant Considerations, and Emerging Biomarkers		Kelsey Lau-Min, MD	Mass General Brigham Cancer Institute
12:00 PM	1:00 PM	Hands on Workshop & Lunch	Liquid Embolics	Sirtex	Ke Zhang, MD PhD	Brigham and Women’s Hospital
					Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
1:00 PM	1:45 PM	Session 13: Multidisciplinary Tumor Board II – HCC	Multidisciplinary Tumor Board I – HCC, Curative Intent and Transplant Decision-Making	Kevin Kim, MD & Boris Hristov, MD	Martin Dib, MD	Beth Israel Deaconess Medical Center
					Baljendra Kapoor, MD	University of Michigan
					Paul Shyn, MD	Harvard Medical School, Brigham and Women’s Hospital
					Suvranu Ganguli, MD	Boston Medial Center/Boston University School of Medicine
					Ameer Elaimy, MD PhD	University of Michigan
					Kelsey Lau-Min, MD	Mass General Brigham Cancer Institute
					Nataliya Razumilava, MD	University of Michigan
1:45 PM	1:55 PM	Session 14: Cholangiocarcinoma	Surgery for Cholangiocarcinoma in 2026: Defining Resectability, Complex Hepatectomy, and Curative-Intent Strategy	Manish Varma, MD & Raul Uppot, MD	Manish Varma, MD	Tufts Medical Center, Boston, MA
1:55 PM	2:05 PM		Liver-Directed Therapy for Cholangiocarcinoma: Y-90, Arterial Infusion, and Conversion to Resection Strategies		Neal Viradia, MD	University of Miami/Bruce Carter VA
2:05 PM	2:15 PM		Radiation Therapy in Cholangiocarcinoma: From Definitive Local Control to Neoadjuvant Bridge and Oligoprogression Management		Hannah Roberts, MD	Mass General Brigham
2:15 PM	2:25 PM		Precision Oncology in Cholangiocarcinoma: Targeted Therapy, Molecular Subtyping, and Clinical Trial-Driven Treatment Selection		Andrea Bullock, MD MPH	Beth Israel Deaconess Medical Center
2:25 PM	3:00 PM	Session 15: Multidisciplinary Tumor Board III – Cholangiocarcinoma	Multidisciplinary Tumor Board II – Cholangiocarcinoma, Complex Biliary Malignancy Management	Charles Kim, MD & Manish Varma, MD	Kumar Krishnan, MD	Massachusetts General Hospital
					Manish Varma, MD	Tufts Medical Center, Boston, MA
					Steve Huang, MD	The University of Texas MD Anderson
					Andrea Bullock, MD MPH	Beth Israel Deaconess Medical Center
					Hannah Roberts, MD	Mass General Brigham
3:00 PM	3:30 PM		Break and Vendor Visiting in Exhibit Lounge
3:30 PM	3:40 PM	Session 16: Neuroendocrine Tumors (NET)	Surgical Cytoreduction for NET Liver Metastases: Defining the Modern Threshold for Aggressive Liver Debulking	John Kachura, MD FSIR & James Frencher, MD	Eduardo Vega, MD	Boston Medical Center
3:40 PM	3:50 PM		Embolotherapy for NET Liver Metastases: Optimizing TAE, TACE, and Y-90 for Durable Disease Control and Symptom Palliation		James Frencher, MD	University of Michigan Medical School
3:50 PM	4:00 PM		PRRT and Systemic Therapy Integration in NETs: Sequencing Theranostics, Somatostatin Analogs, and Targeted Agents for Liver-Dominant Disease		Jennifer Chan, MD	Dana-Farber Cancer Institute
4:00 PM	4:30 PM	Session 17: Multidisciplinary Tumor Board IV – NETs	Multidisciplinary Tumor Board III NETs, Cytoreduction vs Disease Control Strategy	Suvranu Ganguli, MD & Jennifer Chan, MD	Eduardo Vega, MD	Boston Medical Center
					Eric Wehrenberg-Klee, MD	Massachusetts General Hospital
					John Kachura, MD, FSIR	Toronto General Hospital
					Jennifer Chan, MD	Dana-Farber Cancer Institute
					Boris Hristov, MD	University of Michigan
4:30 PM	5:30 PM	Session 18: My Best Save	Case 1	Sid Tavri, MD & Dan Patel, MD	Ajinkya Desai, MD	Massachusetts General Hospital
			Case 2		Alexander Vezeridis, MD	Stanford
			Case 4		Keith Quencer, MD	OHSU
			Case 5		Lauren Ferrara, MD	UMass Chan Medical School
			Case 6		Nick Befera, MD	Duke University
5:30 PM	5:35 PM	Session 19: Best Abstract Award			Resmi Charalel, MD MPH FSIR	Montefiore Einstein